Bluejay Diagnostics, Inc.
BJDX
$1.94
$0.2414.12%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 22.46% | 14.43% | 12.10% | 0.82% | -7.06% |
| Total Depreciation and Amortization | -74.50% | -72.54% | -28.60% | 69.36% | 154.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 72.75% | 154.43% | -15.09% | -101.98% | -71.32% |
| Change in Net Operating Assets | -194.98% | -395.65% | -57.55% | 1,126.50% | 15.23% |
| Cash from Operations | 5.94% | -4.46% | 6.55% | 12.75% | -7.39% |
| Capital Expenditure | 56.45% | 53.95% | 70.23% | 73.29% | 41.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 56.45% | 53.95% | 70.23% | 73.29% | 41.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -41,666.67% | -52,000.00% | -59,962.50% | -320.00% | -500.00% |
| Issuance of Common Stock | 658.71% | 645.18% | 47,166.09% | 17,515.22% | 5,404.50% |
| Repurchase of Common Stock | 99.32% | -- | 100.00% | 97.40% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -344.11% | -325.88% | -11,198.50% | -5,531.50% | -1,976.50% |
| Cash from Financing | 819.49% | 784.56% | 21,594.57% | 7,899.80% | 13,622.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 126.48% | 108.27% | 128.88% | 60.16% | 11.49% |